Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Cold Cap Therapy for the Prevention of Hair Loss in Pediatric and Young Adult Patients Undergoing Chemotherapy for Non-Malignant and Malignant Solid Tumors, The COOLCAP Trial

Trial Status: closed to accrual

This clinical trial tests cold cap therapy for the prevention of hair loss in pediatric and young adult patients undergoing chemotherapy for non-malignant and malignant solid tumors. The chemotherapy that patients are given is known to cause people’s hair to fall out. Cold cap therapy using the Paxman scalp cooling device may help prevent or lessen hair loss in these patients.